Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Optically Active Imidazolone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114920702A discloses a metal-free asymmetric conjugate addition method for synthesizing optically active imidazolone compounds with high enantioselectivity and yield.